<DOC>
	<DOCNO>NCT00826163</DOCNO>
	<brief_summary>We hypothesize ongoing severe airway inflammation COPD may result impairment activation innate immune response</brief_summary>
	<brief_title>Innate Immune Responses Chronic Obstructive Pulmonary Disease ( COPD ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>clinical diagnosis COPD asthma ratio prebronchodilator FEV1 force vital capacity ( FVC ) equal less 0.70 postbronchodilator FEV1 &gt; = 50 % predicted Exacerbation systemic corticosteroid DM , HIV autoimmune disease immunosuppressive therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>